State of New Jersey Common Pension Fund D’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-40,000	Closed	-$480K	–	1663
2019 Q2	$480K	Hold	40,000	–	–	﹤0.01%	880
2019 Q1	$483K	Hold	40,000	–	–	﹤0.01%	869
2018 Q4	$502K	Hold	40,000	–	–	﹤0.01%	870
2018 Q3	$594K	Hold	40,000	–	–	﹤0.01%	882
2018 Q2	$673K	Hold	40,000	–	–	﹤0.01%	899
2018 Q1	$916K	Hold	40,000	–	–	﹤0.01%	864
2017 Q4	$1.03M	Hold	40,000	–	–	﹤0.01%	843
2017 Q3	$590K	Hold	40,000	–	–	﹤0.01%	888
2017 Q2	$558K	Hold	40,000	–	–	﹤0.01%	880
2017 Q1	$682K	Hold	40,000	–	–	﹤0.01%	863
2016 Q4	$412K	Hold	40,000	–	–	﹤0.01%	888
2016 Q3	$404K	Hold	40,000	–	–	﹤0.01%	886
2016 Q2	$449K	Hold	40,000	–	–	﹤0.01%	879
2016 Q1	$546K	Hold	40,000	–	–	﹤0.01%	876
2015 Q4	$759K	Buy	+40,000	New	+$869K	﹤0.01%	874

Other funds holding CNCE

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

State of New Jersey Common Pension Fund D's CNCE Position: Q3 2019 in Review

State of New Jersey Common Pension Fund D sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q3 2019, closing a stake of 40,000 shares — an estimated $480K sold.

State of New Jersey Common Pension Fund D first reported a position in CNCE in Q4 2015 and held it in 15 quarters. The position peaked at $1.03M in Q4 2017. 80 funds tracked by Wall St. Rank hold CNCE as of Q3 2019.

State of New Jersey Common Pension Fund D reported no remaining Concert Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
State of New Jersey Common Pension Fund D sold 40,000 Concert Pharmaceuticals, Inc. shares in Q3 2019, an estimated $480K.
State of New Jersey Common Pension Fund D first reported a position in Concert Pharmaceuticals, Inc. in Q4 2015 and held it in 15 quarters.
State of New Jersey Common Pension Fund D's Concert Pharmaceuticals, Inc. position peaked at $1.03M in Q4 2017.
80 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q3 2019.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q3 2019, filed 23 Oct 2019.